Jump to:

Disease/Disorder

See Cerebrovascular Disorders Part 1

Essentials of Assessment

See Cerebrovascular Disorders Part 1

Cutting Edge/Emerging and Unique Concepts and Practice

Constraint-induced movement therapy (CIMT)

  • Modality: restraining the unaffected limb for 14 days, 90% of waking hours (or modified to 5-6 hours daily), while intensively training the affected limb.
  • Mechanism: Use-dependent increase in reorganization of cortical areas controlling the affected limb.1 High-repetition challenge may also lead to improvements.2
  • Benefits
    • Highly effective for improving upper limb function and activities of daily living (ADL) performance, especially when combined with traditional training and electrical stimulation (e-stim)2
    • Improved motor and functional outcomes – walking independence, balance, mobility, endurance
    • Decreased spatial neglect
  • Barriers: requires 20° active wrist extension, 10° active finger extension, limited spasticity, preserved cognition and balance.

Vagus Nerve Stimulation2,3,4

  • Modality: Invasive or non-invasive delivery of electrical pulses to the vagus nerve
  • Mechanism: Neuromodulator release enhances task-specific cortical plasticity when paired with rehabilitation movements, may also have neuroprotective effects.
  • Benefits
    • Emerging evidence for reduced swallowing impairment within 6 months of stroke
    • Arm impairment reduction in conjunction with high dose task-specific training
    • Improvement of depression, epilepsy, migraine, and movement disorders

Pharyngeal Electrical Stimulation (PES)2,3,5

  • Modality: Peripheral sensory stimulation via electrodes to hypopharyngeal mucosa
  • Mechanism: Increased direct sensory input drives indirect sustainable changes in cerebral control of swallowing
  • Benefits:
    • May improve texture tolerance and swallowing, reducing aspiration and rates of clinical dysphagia
      • Translates to reduced pneumonia and hospital length of stay
    • Best for patients who were mechanically ventilated; may enable decannulation of tracheotomized patients.

Robotics6

  • Modality: Various – exoskeletons, end-effectors, and wearable powered/assistive devices (with motor neuroprosthetics such as WalkAide as related adjuncts).
  • Mechanism: High-intensity, repetitive exercises and precise movements with reduced physical strain speed recovery and stimulate neuroplasticity
  • Benefits
    • Facilitates strengthening and motor relearning of all limbs
    • Engages patients with gaming and challenges
    • Enhanced data collection
    • Safety profile – few side effects; may be utilized in absence of a therapist 2
  • Barriers: limited studies supporting benefits, high cost, technological learning curve

Brain-computer interface (BCI)7

  • Modality: Assistive technologies harness brain signals to drive external devices for patients with severe motor impairments
  • Mechanism: Neuroprosthetic devices/technologies bypass damaged brain tissue via adaptive neuroplasticity of uninvolved distal brain areas. Parts of the nervous system not involved in specific tasks can be harnessed to reconstruct the neural substrate that interacts with a BCI-driven device.
  • Benefits
    • Restores mobility and motor function in conjunction with robotic devices to enable therapy participation
    • Improved communication and quality of life for patients with neurodegenerative conditions
  • Barriers: unreliable technology, high cost, surgical complications of invasive BCI’s

Noninvasive brain stimulation (NIBS) – transcranial magnetic stimulation (rTMS) and direct current stimulation (tDCS)2,8

  • Modality: application of mild magnetic (rTMS) or electrical (tDCS) stimulation to the scalp
  • Mechanism: neuromodulation of plasticity and cortical excitability
  • Benefits
    • Motor function, spasticity, lower limb function, gait, limb apraxia, dysarthria, dysphagia
    • Aphasia, cognition (neglect, memory), mood, post-stroke fatigue, visual field cuts
    • May be more efficacious than deep brain stimulation for central post-stroke pain

Virtual reality (VR) and interactive gaming9

  • Modality: Virtual environments (head-mounted displays or projection) with multisensory input, controlled via devices ranging from mice and joysticks to cameras, sensors, and haptics.
  • Mechanism: Immersive, repetitive skills practice
  • Benefits
    • Upper limb function and ADL completion
    • Walking speed, balance, decreased apraxia and fall risk2
    • Cognitive flexibility, perceptual functioning,2 attention
  •  Effects on grip strength and global motor function remain unclear.  

Minimally invasive hemiplegic shoulder pain (HSP) solutions

  • Modality
    • Pulsed radiofrequency neuromodulation (PRF): High-frequency electrical pulses delivered via needle electrodes (often to the suprascapular nerve)10
      • Mechanism: disrupts nerve pain signaling
      • Benefits
        • Long-term mediation of neuropathic HSP with few adverse effects
        • Shoulder range of motion (ROM) improvements
        • May outperform suprascapular nerve blocks.2
    • High-intensity laser therapy (HILT): Non-invasive high-power focused light applied to the skin
      • Mechanism: reduces peripheral nerve sensitivity, promotes tissue healing.
      • Benefits:
        • Decreased pain and shoulder ROM limitations when paired with therapeutic exercise
        •  Useful for comorbidities like rotator cuff tears.11
  • Further research is needed on rTMS and robot-assisted therapy for HSP.

Rehabilitation Management and Treatments

Current treatment guidelines

The American Heart Association & American Stroke Association have published guidelines for the management and rehabilitation of stroke.2,12,13,14

Stroke recovery is divided into hyperacute (0-24h), acute (1-7d), early subacute (7d-3m), late subacute (3-6m), and chronic (>6m) stages.

Hyperacute and acute stroke management and rehabilitation2, 12

  • Comprehensive stroke centers and stroke systems of care including mobile stroke units improve outcomes.
Acute stroke management flow chart

Figure 1. Acute stroke management, created by R. Thompson using Claude, Sonnet 5.5, Anthropic

  • Dysphagia screening: within 24 hours of admission, instrumental swallow studies within 4 days of admission (or 24 hours post-extubation)
  • Complete multidisciplinary rehabilitation with formal needs assessment before hospital discharge.
    • Early mobilization (24-48h post-stroke) with out-of-bed movements reduces deconditioning and its effects on fatigue, orthostatic hypotension, and endurance.
  • Orpington Prognostic Scale within 72 hours determines early rehabilitation needs and post-acute destination.

Subacute stroke management and rehabilitation

Multidisciplinary rehabilitation teams are often led by physiatrists or neurologists with rehabilitation expertise. Teams include therapists (physical, occupational, recreational), speech-language pathologists (SLP), social workers, neuropsychologists, nurses, and others (e.g. vocational rehabilitation specialists, dieticians, pharmacists).2

  • Priority: comprehensive assessment of current and prior functional, physical, and cognitive status to maximize recovery and prevent complications.
  • Location: Acute inpatient rehabilitation facilities improve community discharge rates compared to lower levels of care such as sub-acute inpatient rehabilitation.2
    • Other settings: day rehabilitation, outpatient, home therapy programs.

Specific rehabilitation foci

  • Motor2
    • Assessment: strength, active/passive ROM, tone, gross/fine motor coordination, balance, apraxia, mobility
      • Reassess balance throughout recovery to provide the least restrictive assistive devices.
      • Quantify via dynamometry, wearable accelerometers, or validated tools (Fugl-Meyer Motor Assessment, Berg Balance Scale).
    • Interventions: strengthening, gait and balance training including tai chi, orthoses, transcutaneous electrical nerve stimulation (TENS), robot-assisted movement therapy, CIMT, and upper extremity interventions to improve ADLs.
      • Functional electrical stimulation (FES) may facilitate movement or compensate for decreased voluntary movement.
      • Treadmill and robot-assisted gait trainings are not superior to task-specific overground training, however these and body weight-supported training may simplify session structuring.
      • Mental practice/motor imagery (MP/MI) is an emerging adjunct to standard and non-conventional therapies for recovery of upper limb movement, speed, and coordination as well as walking speed.
      • Mirror therapy, initially applied to amputation patients, shows preliminary gains in motor function, including walking speed.
      • Not recommended: Amphetamines for motor recovery15
  • Sensation
    • Assessment: sharp/dull, temperature, light touch, vibratory and position sense; performance-based vision exam, hearing exam evaluating peripheral and central auditory function if impairment is suspected
    • Interventions: Include compensatory techniques in the individualized rehabilitation program
      • Active somatosensory discrimination training may begin 6 weeks post-stroke to build discrimination skill and possibly increase affected limb use through learning-based approaches.2
      • Audiology referral as needed
  • Spasticity2
    • Assessment: early evaluation using the modified Ashworth Scale
    • Interventions:
      • Prevention: early mobilization, ROM, positioning, bracing
        • Not recommended: Splints/taping for prevention of wrist/finger spasticity.
      • Medications: tizanidine, dantrolene, baclofen (including intrathecal)
        • Not recommended: Benzodiazepines (recovery delay)
      • Procedures: guided botulinum toxin injections, chemoneurolysis, cryoneurolysis16
      • Contractures: splinting, serial casting, or surgical correction; e-stim and shockwave may be reasonable
  • Cognition
    • Assessment: Screen all patients regularly; full evaluations for appropriate candidates (arousal, attention, visual neglect, learning, memory, executive function, perception, problem solving); broad psychosocial assessment; consider home evaluation
    • Interventions:
      • Pharmacological: Consider off-label stimulants for decreased arousal; acetylcholinesterase inhibitors or NMDA receptor antagonists for vascular cognitive impairment.15
      • Nonpharmacological: compensatory strategies, structured feedback, education of deficits, physical activity (reduces dementia risk).2
      • Visuospatial neglect: prism glasses, mirror therapy, VR, CIMT, limb activation therapy, audio-visual spatial exploration training2
  • Aphasia
    • Assessment: Early recognition and SLP evaluation
    • Interventions: Multidisciplinary treatment during spontaneous recovery and compensatory techniques for persistent deficit; adding neurostimulation may increase gains2
      • Further research is needed on medications including donepezil and memantine17
  • Dysarthria2
    • Assessment: SLP evaluation and oral mechanism exam
    • Interventions: Exercises for articulation, fluency, resonance, respiration, and phonation; compensatory techniques including prosthetics; alternate/augmentative communication devices; telerehabilitation for patients with access barriers.
      • Not recommended: Non-speech oral-motor exercises
  • Dysphagia2
    • Bedside swallow studies miss aspiration in 40-60% of cases, which risks pneumonia – a common cause of post-stroke death
    • Assessment: Screen before oral intake, then formally assess swallowing to determine safe diet consistency/texture. Videofluoroscopy swallowing study or fiberoptic endoscopic evaluation of swallowing can guide rehabilitation
      • Repeat within 3 months of acute discharge
    • Interventions: Diet modification, behavioral swallowing therapy (postural changes, increased sensory input, modified maneuvers, respiratory muscle exercises)
      • Botulinumtoxin or atropine administration may ameliorate sialorrhea
      • PES improves swallowing, texture tolerance, and decannulation rates2,3
      • Percutaneous endoscopy gastrostomy is preferred over nasogastric tube for long-term nutrition.
  • Nutrition
    • Assessment: Nutritionist evaluation and serial weights guide need for laboratory tests (e.g. albumin, prealbumin)
    • Interventions: Diet optimization with supplementation and forced fluids; calorie counts as needed to ensure adequate nutritional status and hydration
  • Skin
    • Up to 25% of hospitalized stroke patients sustain pressure injuries or bruising.2
    • Assessment: On admission and daily; the Braden Scale informs breakdown risk.
    • Interventions: pressure-relieving surfaces and repositioning, friction minimization, barrier products, optimizing nutrition/hydration, wound care consultation.
  • Hemiplegic Shoulder Pain (HSP) and subluxation2
    • Assessment: sensory/motor exam; history of nociceptive and neuropathic pain; assess risk factors (subluxation, soft tissue injury, neglect, diabetes)
    • Interventions: oral medications, intra-articular steroids, limb support, stretching, thermal modalities, peripheral nerve stimulation (FES/NMES), spasticity management, shockwave, or suprascapular nerve block referral.
      • Prevention: monitoring, positioning, hemiplegic limb support (wheelchair arm trough, shoulder harness/sling, taping), trauma prevention, avoiding uncontrolled abduction and overhead pulleys, transfer precautions.
      • Twice-daily shoulder abduction and elbow extension in external rotation may minimize contracture.
  • Central Post-Stroke Pain (CPSP)2
    • Assessment: Reported pain after a stroke corresponding to the lesion area, not accounted for by nociceptive or peripheral neuropathic etiologies.
      • Diagnosis of exclusion
    • Interventions: First line: duloxetine, lamotrigine, and amitriptyline. Second line: gabapentin, pregabalin.
  • Post-Stroke Seizures12, 18
    • Early (<7d) seizures are provoked by the stroke injury; late (>7d) seizures reflect persistent instability of the healing brain and may herald post-stroke epilepsy.
    • Assessment: clinical, EEG, prolactin level for confirmation; address reversible causes
    • Interventions:
      • Benzodiazepines are first line for status epilepticus
      • Not recommended: primary seizure prophylaxis
      • Anticonvulsants (levetiracetam, lamotrigine preferred): short-term for most early seizures, long-term for late seizures
  • Mental Health2
    • Post-stroke depression (PSD) and anxiety (PSA) affect up to 1/3rd and 1/4th of stroke patients, respectively, and PSD increases mortality and recurrent strokes.
    • Assessment: Screen promptly, repeat at 3 and 6 months and lifelong.Use validated scales to assess fatigue and sleep.
    • Interventions:
      • Pharmacological: Selective serotonin reuptake inhibitors (SSRIs) treat but don’t prevent PSD.
      • Modafinil for post-stroke fatigue is under investigation.
      • Nonpharmacological: Cognitive-behavioral therapy (CBT) including telehealth and group formats, light therapy for fatigue, treatment of premorbid sleep apnea, exercise for PSD.
  • Fall risk
    • Assessment: evaluate annually using established tools; address fear of falling
    • Prevention: low beds, bed alarms or direct observation, wheelchair belts, tai chi, active gaming, exercise with dual-task training, avoid tethers in cognitively impaired patients2
  • Bladder management2
    • Urinary incontinence affects up to 79% of hospitalized stroke patients and typically resolves with time.
    • Assessment: Detailed history; consider premorbid, functional, and reversible causes
    • Interventions: Remove indwelling catheters within 24 hours of inpatient rehabilitation; intermittent or external catheterization temporarily with bladder scans and timed voids; TENS and e-stim may benefit early subacute patients.
  • Bowel management
    • Constipation is the most common bowel dysfunction and improves by rehabilitation discharge.2
    • Assessment: Detailed history and medication review
    • Interventions: laxatives, stool softeners, bowel training, education regarding diet, fluids, and exercise
  • Medical Management
    • Blood pressure management: Goal 130/80 mmHg with patient-specific exceptions (e.g. thrombectomy);Titrate antihypertensives in neurologically stable patients.2
    • Deep vein thrombosis (DVT) prophylaxis: early mobilization, subcutaneous heparin or low molecular weight heparin (unless contraindicated), and continuous or intermittent sequential compression devices. Consider an inferior vena cava filter if at risk for pulmonary embolism and anticoagulation is contraindicated.
      • Not recommended: Elastic compression stockings2
    • Medication considerations: Avoid central nervous system depressants (e.g. neuroleptics, benzodiazepines, barbiturates), which are associated with poorer outcomes
    • Infection: Prevent, promptly identify, and treat pneumonia and urinary tract infections. Treat underlying cause of fevers.

Chronic stroke management2

  • After inpatient rehab: Up to 40% of patients use a wheelchair at discharge, and over 21% report unmet rehabilitation needs at one year. The rehabilitation team supports transition to home by arranging durable medical equipment (DME), home rehabilitation, home health, outpatient therapy, medical appointments, and support group referrals.
    • Outpatient therapy within 30 days of discharge home reduces readmissions.
  • Ongoing Management
    • Common Components: exercise programs, mobility DME, adaptive ADL devices, home modifications, fall prevention, and attention to return to work, driving, sexual dysfunction, and stroke risk factors/comorbidities.
    • Exercise: Individualized moderate-intensity program initiated in rehab and continued at home, combining aerobic, strength (bilateral resistance training), and balance training for 150-300 minutes per week.2
  • Secondary Stroke Prevention2,13,14
    • Medical: hypertension and hyperglycemia treatment; anticoagulation for atrial fibrillation (or cardiac monitoring for suspected occult arrhythmia); antiplatelet therapy for cerebral ischemia; carotid stenosis management, patent foramen ovale closure in selected patients, coronary heart disease prevention (GLP-1 agents may be beneficial), lipid lowering therapy, sleep apnea treatment
    • Lifestyle: Mediterranean diet for weight management, limiting alcohol, avoiding long sedentary periods, exercise, smoking/stimulant cessation.
  • Chronic urinary incontinence: pelvic floor muscle training, combined with other treatments including bladder training.
  • Pseudobulbar affect: dextromethorphan/quinidine, consider antidepressants.
  • Return to work or driving: assess via comprehensive physical exam, vocational rehabilitation, and driving rehabilitation

Coordination of care

A multidisciplinary team is essential to maximize supports and resources; engage caregivers early and share assessment conclusions with them.

Patient & family education

  • Main Principles: Awareness of deficits, preservation of rehabilitation gains, minimizing complications and risk factors, community resources, and reintegration.
    • Teach-back strategies encourage comprehension and adherence.2,14
  • Essential Educational Topics
    • See “Secondary Stroke Prevention” section
    • Continued therapy participation and regular primary care visits, with screenings for adverse social determinants of health
    • Monitor for post-stroke complications, especially mental health, continued exercise, skin protection, nutrition and aspiration precautions
      • Psychoeducation with patients and families regarding PSD/PSA improves outcomes2

Outcome measures

Functional status and magnitude of gains, discharge disposition, hospital readmissions, comorbidity burden, and cognitive impairment are key indicators of post-stroke rehabilitation.

Table 1. Common Scales19

Table 1 created by R. Thompson using Claude, Sonnet 5.5, Anthropic

Gaps in the Evidence-Based Knowledge

  • Optimal rehabilitation protocols and validated support tools including treatment approach, timing, and dose especially in the early subacute phase
  • CPSP diagnostic criteria, standardized measurement, and medication approaches
  • Efficacy of SSRIs for reducing pseudobulbar episode frequency/severity; established pharmacological and nonpharmacological treatments for PSA, especially in patients with cognitive deficits
  • Dysphagia reassessment beyond 6-12 months post stroke.2
  • Rehabilitation interventions to facilitate return to driving
  • Risks and benefits of complementary and alternative medicine (biological therapy interactions) and long-term benefit of tai chi2,20

References

  1. Blanton S, Wilsey H, Wolf SL. Constraint-induced movement therapy in stroke rehabilitation: perspectives on future clinical applications. NeuroRehabilitation. 2008;23(1):15-28.
  2. Richards LG, Ifejika NL, Stein J, et al. 2026 Guideline for Adult Stroke Rehabilitation and Recovery: A Guideline From the American Heart Association and American Stroke Association. Stroke. Published online August 27, 2026. doi:10.1161/STR.0000000000000536
  3. Wilkinson G, Everton LF, Bath PM, Benfield JK. Swallowing therapy for dysphagia in acute and subacute stroke. Cochrane Database of Systematic Reviews 2026, Issue 8. Art. No.: CD000323. DOI: 10.1002/14651858.CD000323.pub4. Accessed 06 October 2026.
  4. Proietti, F., Ottaviani, M.M., Burchi, E., Vivacqua, G., Anzini, G., Ricciuti, R.A., Capone, F., Macefield, V.G., Di Lazzaro, V. and Marano, M. (2025), Vagus Nerve Stimulation in Movement Disorders, from Principles to a Systematic Review of Evidence. Mov Disord, 40: 2559-2577. https://doi.org/10.1002/mds.70044
  5. Scutt, Polly, Lee, Han S., Hamdy, Shaheen, Bath, Philip M., Pharyngeal Electrical Stimulation for Treatment of Poststroke Dysphagia: Individual Patient Data Meta-Analysis of Randomised Controlled Trials, Stroke Research and Treatment, 2015, 429053, 8 pages, 2015. https://doi.org/10.1155/2015/429053
  6. Weber LM, Stein J. The use of robots in stroke rehabilitation: A narrative review. Harvey RL, ed. NRE. 2018;43(1):99-110. doi:10.3233/NRE-172408
  7. Carelli L, Solca F, Faini A, et al. Brain-Computer Interface for Clinical Purposes: Cognitive Assessment and Rehabilitation. Biomed Res Int. 2017;2017:1695290. doi:10.1155/2017/1695290
  8. Claflin ES, Krishnan C, Khot SP. Emerging Treatments for Motor Rehabilitation After Stroke. The Neurohospitalist. 2015;5(2):77-88. doi:10.1177/1941874414561023
  9. Laver KE, George S, Thomas S, Deutsch JE, Crotty M. Virtual reality for stroke rehabilitation. Cochrane Stroke Group, ed. Cochrane Database of Systematic Reviews.Published online February 12, 2015. doi:10.1002/14651858.CD008349.pub3
  10. Park D, Chang MC. The mechanism of action of pulsed radiofrequency in reducing pain: a narrative review. J Yeungnam Med Sci. 2022 Jul;39(3):200-205. doi: 10.12701/jyms.2022.00101. Epub 2022 Apr 7. PMID: 35385898; PMCID: PMC9273139.
  11. Bathla M, Goyal M, Kalra R, Singh C, Goyal K. The clinical impact of high intensity laser therapy on post stroke shoulder pain and dysfunction associated with hemiplegia: a systematic review. Neurol Sci. 2026 Apr 6;47(5):403. doi: 10.1007/s10072-026-09004-5. PMID: 41936741.
  12. Prabhakaran S, Gonzalez NR, Zachrison KS, et al. 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2026;57(8):e316-e436. doi:10.1161/STR.0000000000000513
  13. Bushnell C, Kernan WN, Sharrief AZ, et al. 2024 Guideline for the Primary Prevention of Stroke: A Guideline From the American Heart Association/American Stroke Association.
  14. Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association.
  15. Wu Q-E, Zhou A-M, Han Y-P, et al. Poststroke depression and risk of recurrent stroke: A meta-analysis of prospective studies. Medicine (Baltimore). 2019;98(42):e17235. doi:10.1097/MD.0000000000017235
  16. Boissonnault È, Pick A, Pereira J, Li S, Winston P. Emerging Role of Cryoneurolysis in Spasticity Management: A Narrative Review. Phys Med Rehabil Clin N Am. 2026 May;37(2):269-280. doi: 10.1016/j.pmr.2026.01.009. Epub 2026 Feb 24. PMID: 42062019.
  17. Cichon N, Wlodarczyk L, Saluk-Bijak J, Bijak M, Redlicka J, Gorniak L, Miller E. Novel Advances to Post-Stroke Aphasia Pharmacology and Rehabilitation. J Clin Med. 2021 Aug 24;10(17):3778. doi: 10.3390/jcm10173778. PMID: 34501229; PMCID: PMC8432240.
  18. Wolcott ZC, Freund BE, Tatum WO, Feyissa AM. Antiseizure medications for primary and secondary seizure prevention after stroke. Front Neurol. 2025 Jul 8;16:1648064. doi: 10.3389/fneur.2025.1648064. PMID: 40697571; PMCID: PMC12279485.
  19. Pise, O., Kamble, S. & Ghorpade, A. Assessment of multidimensional functional recovery post-stroke: a systematic review of outcome measures and their psychometric properties. BMC Neurol 26, 376 (2026). https://doi.org/10.1186/s12883-026-04903-8
  20. Rabito MJ, Kaye AD. Complementary and Alternative Medicine and Cardiovascular Disease: An Evidence-Based Review. Evidence-Based Complementary and Alternative Medicine. 2013;2013:1-8. doi:10.1155/2013/672097

Original Version of the Topic

Anne F. Ambrose, MD MS. Cerebrovascular Disorders Part 2 (Management and Treatment, Cutting Edge concepts in practice, Gaps in evidence based practice). 10/3/2010

Previous Revision(s) of the Topic

Rani Haley Lindberg, MD, Mustafa Khan, MD. Cerebrovascular Disorders Part Two: Rehabilitation Management and Treatments. 5/5/2016

Rani Haley Lindberg, MD, Sarah Victoria Hunton, MD. Cerebrovascular Disorders Part Two: Rehabilitation Management and Treatments. 12/15/2020

Sarah Hunton, MD, Rani Gardner, MD, Suzanne Abou-Diab, MD, Bilal Ahsan. Stroke and Other Cerebrovascular Disorders Part Two: Rehabilitation Management and Treatments. 1/3/2024

Author Disclosure

Miguel Escalon, MD, MPH
Nothing to Disclose

Rachel Thompson, MD
Nothing to Disclose